1.Robbins MS, Lipton RB: The epidemiology of primary headache disorders. Semin Neurol. 2010, 30 (2): 107-119. 10.1055/s-0030-1249220.
2.Halay, S., Saror, S., Abdalla, A., Balla, S., Elmukashfi, T., Awadalla, H., Abdelrahman, A., Swareldahab, Z., Amara, Z., Malik, E., Mirgani, K. and Mohmed, H., 2021. Prevalence of Migraine and Trigger Factors among Adult Rural Sudanese Population 2018.
3.Noseda, R. and Burstein, R., 2021. Migraine pathophysiology: Anatomy of the trigeminovascular pathway and associated neurological symptoms, cortical spreading depression, sensitization, and modulation of pain.
4. Wessman, M. et al. A susceptibility locus for migraine with aura, on chromosome 4q24. Am. J. Hum. Genet. 70, 652–662 (2002).
5. Moskowitz, M. A. & Macfarlane, R. Neurovascular and molecular mechanisms in migraine headaches. Cerebrovasc. Brain Metab. Rev. 5, 159–177 (1993).
6. May, A. & Goadsby, P. J. The trigeminovascular system in humans: pathophysiologic implications for primary headache syndromes of the neural influences on the cerebral circulation. J. Cereb. Blood Flow Metab. 19, 115–127 (1999).
7. El-Metwally, A., Toivola, P., AlAhmary, K., Bahkali, S., AlKhathaami, A., Al Ammar, S., Altamimi, I., Alosaimi, S., Jawed, M. and Almustanyir, S., 2021. The Epidemiology of Migraine Headache in Arab Countries: A Systematic Review.
8. Zarifoğlu, M., Karli, N. and Taşkapilioğlu, Ö., 2021. Can ID MigraineTM be Used as a Screening Test for Adolescent Migraine?.
9. Deleu, D., Khan, M., Humaidan, H., Al Mantheri, Z. and Al Hashami, S., 2021. Prevalence and Clinical Characteristics of Headache in Medical Students in Oman..
10. Wang X, Sun J, Xing Y, Zhou H, Zhao Y, Zhu Y. The Prevalence and Awareness of Migraine Among University Students in Harbin, China. J Oral Facial Pain Headache. 2015 Fall;29(4):384-9. doi: 10.11607/ofph.1521. PMID: 26485386
11. Al-Hashel JY, Ahmed SF, Alroughani R, Goadsby PJ. Migraine among medical students in Kuwait University. J Headache Pain. 2014 May 10;15(1):26. doi: 10.1186/1129-2377-15-26. PMID: 24886258; PMCID: PMC4029817
12. Genizi J, Gordon S, Kerem NC, Srugo I, Shahar E, Ravid S. Primary headaches, attention deficit disorder and learning disabilities in children and adolescents. J Headache Pain. 2013 Jun 27;14(1):54. doi: 10.1186/1129-2377-14-54. PMID: 23806023; PMCID: PMC3698063.
13. Oztora S, Korkmaz O, Dagdeviren N, Celik Y, Caylan A, Top MS, Asil T. Migraine headaches among university students using ID Migraine test as a screening tool. BMC Neurol. 2011 Aug 19;11:103. doi: 10.1186/1471-2377-11-103. PMID: 21854556; PMCID: PMC3176162.
14. Ofovwe GE, Ofili AN. Prevalence and impact of headache and migraine among secondary school students in Nigeria. Headache. 2010 Nov;50(10):1570-5. doi: 10.1111/j.1526-4610.2010.01776.x. Epub 2010 Oct 14. PMID: 20946430.
15. Basdav J, Haffejee F, Puckree T. Impact of headaches on university students in Durban, South Africa. Springerplus. 2016 Sep 29;5(1):1679. doi: 10.1186/s40064-016-3372-1. PMID 27733981; PMCID: PMC5042922.
16.Goadsby, P. J., Lipton, R. B. & Ferrari, M. D. Migraine — current understanding and treatment. N. Engl. J. Med. 346, 257–270 (2002).
17.Knight, Y. E. & Goadsby, P. J. The periaqueductal grey matter modulates trigeminovascular input: a role in migraine? Neuroscience 106, 793–800 (2001).
18.Goadsby, P. J., Edvinsson, L. & Ekman, R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann. Neurol. 28, 183–187 (1990).
19. Sarchielli, P., Alberti, A., Codini, M., Floridi, A. & Gallai, V. Nitric oxide metabolites, prostaglandins and trigeminal vasoactive peptides in internal jugular vein blood during spontaneous migraine attacks. Cephalalgia 20, 907–918 (2000).
20. Goadsby, P. J. & Edvinsson, L. The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann. Neurol. 33, 48–56 (1993).
21.Olesen, J., Larsen, B. & Lauritzen, M. Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine. Ann. Neurol. 9, 344–352 (1981).
22.Limmroth, V. et al. Changes in cerebral blood flow velocity after treatment with sumatriptan or placebo and implications for the pathophysiology of migraine. J. Neurol. Sci. 138, 60–65 (1996).